MI&T Congressi
C

Current Standards of Care in SCLC

By MI&T Congressi FEATURING Charles Rudin
By MI&T Congressi FEATURING Charles Rudin
192 views
July 18, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Related Content

AUTOPLAY
35:40
Balazs Halmos

Year in Review: Lung Cancer

57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
36:14
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

Feat. B. Halmos
16:10
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOM…

Feat. L. Raez
25:18
Janakiraman Subramanian

Updates in Small Cell Lung Carcinoma

11:24
For-Shing Lui

Lambert-Eaton Myasthenic Syndrome (LEMS) - Clinical Pearls

17:22
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "SCLC Treatment Evolution - Debunking Myths…

Feat. A. Chiang
18:35
2023 Evolution Conference

Recent Updates in SCLC

Feat. S. Kazmi
23:05
Fayez Kheir

Microwave Ablation for Malignant Airway Disease

17:24
Janakiraman Subramanian

Lambert-Eaton Myasthenic Syndrome in SCLC

22:57
Total Health

Lung Cancer Screening - Best of Lung 2023

Feat. C. Olazagasti
25:30
Andrew Gordon

Update on Lambert Eaton Myasthenia Syndrome

09:50
Integrity CE

Overview of ES/LS-SCLC & New Data

Feat. A. Patel, M. Baumgart, S. Liu, G. Dy
12:10
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "BEAT Trials and Neoadjuvant Strategies - A…

Feat. M. Marmarelis
19:41
Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

11:26
Nebraska Oncology Society

ASCO® 2024 Review: Practice-Changing Developments in LS-SCLC and ES-…

Feat. V. Lam
20:43
GRACE

Newer Types of Treatment for Lung Cancer: ADCs and Bispecifics

Feat. L. Bazhenova
10:49
Niels Reinmuth

CASPIAN Trial: Clinical Implications of a 3-Year OS Update of Durval…

10:19
Yale Cancer Center

Using Biomarkers in Clinical Management of Patients With ES-SCLC

Feat. A. Chiang
14:12
MI&T Congressi

Current and Future Options for Relapsed SCLC

Feat. L. Paz-Ares